| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/15/2007 | US7217414 Methods of preventing peritonitis by administering lactic acid bacterium |
| 05/15/2007 | CA2374767C Optically active quinoline carboxylic acid derivatives having 7-pyrrolidine substitutes causing optical activity and a process for preparing thereof |
| 05/15/2007 | CA2249736C Caprine arthritis-encephalitis virus provides immunoprotection against hiv-1 infection |
| 05/15/2007 | CA2196100C Saccharomyces treatment to diminish campylobacter and salmonella populations in poultry |
| 05/15/2007 | CA2168885C Vaccine compositions |
| 05/15/2007 | CA2149922C Genetically engineered glutaminase and its use in antiviral and anticancer therapy |
| 05/15/2007 | CA2130452C Altered antibodies, products and processes relating thereto |
| 05/15/2007 | CA2087958C Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis |
| 05/10/2007 | WO2007053724A2 Crystalline forms of cefdinir potassium salt |
| 05/10/2007 | WO2007053384A1 Dispensing brush with replaceable cartridge/handle part |
| 05/10/2007 | WO2007052943A1 Novel antifungal triazole derivatives |
| 05/10/2007 | WO2007052738A1 Medicinal composition showing improved drug absorbability |
| 05/10/2007 | WO2007052629A1 Oligo double-stranded rna and pharmaceutical composition |
| 05/10/2007 | WO2007052615A1 Pyridine derivative substituted by heterocycle and fungicide containing the same |
| 05/10/2007 | WO2007051630A1 Heterocyclic compounds and their use as antifouling agents |
| 05/10/2007 | WO2007051468A2 Preparation of an antibiotic crystalline fusidic acid |
| 05/10/2007 | WO2007051462A2 Use of tetraorganosilicon compounds |
| 05/10/2007 | WO2007031574A3 Therapeutic use of outer shigella protein f (os pf) |
| 05/10/2007 | WO2007029029A3 Tetracyclic indole derivatives as antiviral agents |
| 05/10/2007 | WO2007022520A3 Antibody-mediated enhancement of immune response |
| 05/10/2007 | WO2007018463A3 Interaction of moraxella catarrhalis with epithelial cells, extracellular matrix proteins and the complement system |
| 05/10/2007 | WO2007008539A3 Pyranopyridine compounds |
| 05/10/2007 | WO2006123164A3 Lps-binding and bactericidal cytokines and interferons |
| 05/10/2007 | WO2006118607A3 Hcv inhibitors with carbazole structure |
| 05/10/2007 | WO2006112716A3 Nutritional supplement for hiv patients |
| 05/10/2007 | WO2006037090A3 Drug-phosphate conjugates as prodrugs |
| 05/10/2007 | US20070106062 Attenuated vif DNA immunization cassettes for genetic vaccines |
| 05/10/2007 | US20070105949 Intermediates for the preparation of lipoxin A4 analogs |
| 05/10/2007 | US20070105933 Amino alcohol compounds |
| 05/10/2007 | US20070105900 Pharmaceutical compounds |
| 05/10/2007 | US20070105879 Ready-for-use injectable solution of 9-((1,3-dihydroxypropan-2-iloxy)methyl)-2-amine-1h-purin-6(9h)-one, sterile, stable; closed system for packing the solution, process for eliminating alkaline residuals of 9-((1,3-dihydroxypropan-2-iloxy)methyl)-2-amine-1h-purin-6 (9h)-one crystals; pharmaceutical presentation as a closed system ready-for-use; uses and methods |
| 05/10/2007 | US20070105860 Biphenylcarboxylic Amide Derivatives as p38 Kinase Inhibitors |
| 05/10/2007 | US20070105859 4-Phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (mek) inhibitors |
| 05/10/2007 | US20070105826 Novel fusidic acid derivatives |
| 05/10/2007 | US20070105813 Disialoundecasaccharide chain asparagine/fatty acid amide and medical drug containing the same |
| 05/10/2007 | US20070105812 Treating HIV-1 viral infections by administering a phospholipid choline derivative, e.g., 1-dodecanamido-2-decyloxypropyl-3-phosphocholine |
| 05/10/2007 | US20070105760 Process for the preparation of echinocandin derivatives |
| 05/10/2007 | US20070105225 DNA and proteins or peptides specific of bacteria of the Neisseria meningitidis species, methods for obtaining them and biological applications thereof |
| 05/10/2007 | US20070105219 Retrovirus from the HIV group and its use |
| 05/10/2007 | US20070105191 Capable of inducing chondrocyte proliferation; Chinese Hamster Ovary, an Escheria coli or a yeast host cell with an expression vector |
| 05/10/2007 | US20070105167 Virulence Associated Nucleic Acid Sequences and Uses Thereof |
| 05/10/2007 | US20070105135 Charged compounds comprising a nucleic acid binding moiety and uses therefor |
| 05/10/2007 | US20070104736 Culturing a non-typeable Haemophilus influenzae strain having a mutation in htrB gene, wherein the htrB mutation produces a mutant non-typeable Haemophilus influenzae; purifying the mutant endotoxin |
| 05/10/2007 | US20070104731 Helicobacter proteins and vaccines |
| 05/10/2007 | US20070104724 Attaching substances to microorganisms |
| 05/10/2007 | US20070104702 Method for treating diseases associated with changes of qualitative and/quantitative composition of blood extracellular dna |
| 05/10/2007 | CA2784168A1 Growth control of oral and superficial microorganisms using gallium compounds |
| 05/10/2007 | CA2627585A1 Rnai inhibition of influenza virus replication |
| 05/10/2007 | CA2609985A1 Modulation of cell barrier dysfunction |
| 05/09/2007 | EP1783227A1 Humanized anti-CCR2 antibodies and methods of use therefor |
| 05/09/2007 | EP1783226A1 AAV structural protein, production and use thereof |
| 05/09/2007 | EP1783225A1 AAV structural protein, production and use thereof |
| 05/09/2007 | EP1783224A2 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 05/09/2007 | EP1783141A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/09/2007 | EP1783129A1 Spiropiperidyl rifamycins for the treatment of microbacterial infections |
| 05/09/2007 | EP1783128A1 Heterocyclic compounds and their use as antifouling agents |
| 05/09/2007 | EP1782826A1 PQS and c-diGMP and its conjugates as adjuvants and their uses in pharmaceutical compositions |
| 05/09/2007 | EP1782820A1 Method of screening toxin-neutralizing peptide, stx2 inhibitory peptide and vero toxin-neutralizing agent |
| 05/09/2007 | EP1782816A1 Water-based medicinal composition containing azithromycin and method of preparing the same |
| 05/09/2007 | EP1781777A1 Method for the genetic activation of cells and uses of said cells |
| 05/09/2007 | EP1781679A1 Antibacterial agents |
| 05/09/2007 | EP1781670A1 Rifamycin derivatives for treating microbial infections |
| 05/09/2007 | EP1781669A2 Antibacterial agents |
| 05/09/2007 | EP1781662A1 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
| 05/09/2007 | EP1781653A1 3,4-disubstituted pyrazoles as cyclin dependent kinases (cdk) or aurora kinase or glycogen synthase 3 (gsk-3) inhibitors |
| 05/09/2007 | EP1781650A1 Novel compounds having an anti-bacterial activity |
| 05/09/2007 | EP1781643A1 Oxindole oxazolidinones as antibacterial agents |
| 05/09/2007 | EP1781642A1 Oxazolidinones containing oxindoles as antibacterial agents |
| 05/09/2007 | EP1781632A1 Pyrans for use in the treatment of infection |
| 05/09/2007 | EP1781600A1 Benzoic acid derivatives as non-nucleoside reverse transcriptase inhibitors |
| 05/09/2007 | EP1781302A1 New use |
| 05/09/2007 | EP1781290A2 Anti-inflammatory agents |
| 05/09/2007 | EP1781289A1 Thienopyridines for treating hepatitis c |
| 05/09/2007 | EP1654229B1 Piperidine derivatives as ccr5 receptor modulators |
| 05/09/2007 | EP1601769B1 Papillosin antimicrobial peptide, a gene for coding said peptide, a vector, a transformed organism and a compound containing said organism |
| 05/09/2007 | EP1601768B1 Anti-microbial peptide known as halocyntin, gene coding for said peptide, vector, transformed organism and composition containing said peptide |
| 05/09/2007 | EP1597238B1 Hiv replication inhibiting pyrimidines and triazines |
| 05/09/2007 | EP1501796B1 3-(pyridinyl-amino)-1h-indole-2-carboxylic acid derivatives as interleukin-4 gene expression inhibitors |
| 05/09/2007 | EP1408941B1 Use of a pharmaceutical composition comprising two quaternary ammonium compounds and an organometallic one in the treatment of viral and fungal infections and diseases |
| 05/09/2007 | EP1191931B1 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2 |
| 05/09/2007 | EP1137792B1 A recombinant vector expressing multiple costimulatory molecules and uses thereof |
| 05/09/2007 | EP1073447B1 N1-modified glycopeptides |
| 05/09/2007 | EP1012244B1 Rhabdoviruses with reengineered coats |
| 05/09/2007 | EP0793675B9 Hiv-1- and hiv-2-peptides for inhibition of membrane fusion-associated events, including hiv transmission |
| 05/09/2007 | EP0692029B1 Genetically engineered glutaminase and its use in therapy |
| 05/09/2007 | CN1961002A Binding molecules capable of neutralizing rabies virus and uses thereof |
| 05/09/2007 | CN1960976A 4-carbox pyrazole derivates useful as anti-viral agents |
| 05/09/2007 | CN1960763A Anti-vaginitis compositions |
| 05/09/2007 | CN1960758A Remedy or preventive for arthritis |
| 05/09/2007 | CN1960743A Herbal composition |
| 05/09/2007 | CN1960740A Method of preventing nodavirus infection and therapeutic method |
| 05/09/2007 | CN1960738A Antibacterial composition |
| 05/09/2007 | CN1960716A Oral preparations and process for production thereof |
| 05/09/2007 | CN1958608A Method for preparing specificity IgY of anti influenza of birds, and preparation |
| 05/09/2007 | CN1958601A Quick separating and purifying protein 1 of singkwa fowelgourd |
| 05/09/2007 | CN1958584A Derivative of fibrauretine, and preparation method |
| 05/09/2007 | CN1958073A External use medicament for onychomycosis in fingernails or toe nails |
| 05/09/2007 | CN1958072A Immunoglobulin for anti gosling plague |
| 05/09/2007 | CN1958071A Dual high immunity immunoglobulin for anti reproduction of pig and breathing syndrome, second type cirque virus of pig |
| 05/09/2007 | CN1958070A Triple high immunity immunoglobulin for anti transmissible gastroenteritis of pig, epidemic diarrhea of pig, and rotavirus of pig |